|
Real-World Treatment Patterns Among French Patients With Metastatic Castration-Resistant Prostate Cancer Under Abiraterone or Enzalutamide
Lucie-Marie Scailteux
,
Sebastien Vincendeau
,
Gwenaelle Gravis
,
Romain Mathieu
,
Frederic Balusson
Journal articles
hal-04121016v1
|
|
Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial
Stéphane Culine
,
Valentin Harter
,
Clémentine Krucker
,
Gwénaëlle Gravis
,
Aude Fléchon
Journal articles
hal-04195179v1
|
|
A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study
Gwenaelle Gravis
,
Patricia Marino
,
Daniel Olive
,
Frederique Penault-Llorca
,
Jean-Pierre Delord
Journal articles
hal-04109560v1
|
|
Self-reported functional assessment after treatment for prostate cancer: 5-year results of the prospective cohort VICAN
Géraldine Pignot
,
Rajae Touzani
,
Marc-Karim Bendiane
,
Julien Mancini
,
Jochen Walz
Journal articles
inserm-04039329v1
|
|
The Psychological Distress of Cancer Patients following the COVID-19 Pandemic First Lockdown: Results from a Large French Survey
Patricia Marino
,
Rajae Touzani
,
Jihane Pakradouni
,
Patrick Ben Soussan
,
Gwenaelle Gravis
Journal articles
inserm-04042655v1
|
|
Chemotherapy following immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma
Lucie Meynard
,
Derek Dinart
,
Blandine Delaunay
,
Aude Flechon
,
Carolina Saldana
Journal articles
hal-03836416v1
|
|
Escherichia coli –Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer
Anne-Gaëlle Goubet
,
Leonardo Lordello
,
Carolina Alves Costa Silva
,
Isabelle Peguillet
,
Marianne Gazzano
Journal articles
hal-03951702v1
|
|
Should Prostate Cancer Patients With History of Cardiovascular Events Be Preferentially Treated With Luteinizing Hormone-Releasing Hormone Antagonists?
Steven Tisseverasinghe
,
Marwan Tolba
,
Fred Saad
,
Gwenaelle Gravis
,
Boris Bahoric
Journal articles
hal-04084956v1
|
|
Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial
Yann-Alexandre Vano
,
Réza Elaidi
,
Mostefa Bennamoun
,
Christine Chevreau
,
Delphine Borchiellini
Journal articles
hal-04072026v1
|
|
Impact of active surveillance for prostate cancer on the risk of depression and anxiety
Davidson Sypre
,
Géraldine Pignot
,
Rajae Touzani
,
Patricia Marino
,
Jochen Walz
Journal articles
inserm-04048149v1
|
|
Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial
Émilien Billon
,
Gwenaelle Gravis
,
Arnaud Guille
,
Nadine Carbuccia
,
José Adélaïde
Journal articles
hal-04085310v1
|
|
Cabozantinib-nivolumab sequence in metastatic renal cell carcinoma: The CABIR study
Yann-Alexandre Vano
,
Letuan Phan
,
Gwenaelle Gravis
,
Iphigenie Korakis
,
Friederike Schlurmann
Journal articles
hal-04084994v1
|
|
Cabozantinib-nivolumab sequence in metastatic renal cell carcinoma: The CABIR study
Yann‐alexandre Vano
,
Letuan Phan
,
Gwenaelle Gravis
,
Iphigénie Korakis
,
Friederike Schlürmann
Journal articles
hal-04085018v1
|
|
A non-inferiority randomized phase III trial of standard immunotherapy versusreduced dose intensity in responding patients with metastatic cancer: MOIO study.
Gwenaelle Gravis
,
Daniel Olive
,
Patricia Marino
,
Frederique Madeleine Penault-Llorca
,
Jean-Pierre Delord
Journal articles
hal-03929783v1
|
|
Multicentric phase II trial of TI‐CE high‐dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors
Christine Chevreau
,
Christophe Massard
,
Aude Flechon
,
Rémy Delva
,
Gwenaëlle Gravis
Journal articles
hal-03208728v1
|
|
Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy?
Arnaud Méjean
,
Alain Ravaud
,
Simon Thezenas
,
Christine Chevreau
,
Karim Bensalah
Journal articles
hal-03345230v1
|
|
Feasibility and first results of digital patient-reported outcomes measures (PROMs) data collection for patients with localized prostate cancer at diagnosis.
Geraldine Pignot
,
Marion Picini
,
Patricia Marino
,
Naji Salem
,
Stanislas Rybikowski
Journal articles
hal-03623123v1
|
|
Prognostic Risk Classification for Biochemical Relapse-Free Survival in Oligometastatic Recurrent Prostate Cancer Determined by Choline PET
Gwenaelle Gravis
,
Aurélie Autret
,
Morgane Guibert-Broudic
,
Thomas Dubergé
,
Christophe Zemmour
Journal articles
hal-03623562v1
|
|
Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial
T.K. Choueiri
,
J. Larkin
,
S. Pal
,
R.J. Motzer
,
B.I. Rini
Journal articles
hal-03623572v1
|
|
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 Study
Stéphane Culine
,
Aude Fléchon
,
Gwenaelle Gravis
,
Guilhem Roubaud
,
Yohann Loriot
Journal articles
hal-03631553v1
|
|
Cost-effectiveness Analysis of Innovative Therapy for Patients with Newly Diagnosed Hormone-Sensitive Metastatic Prostate Cancer
Rémi Pelloux-Prayer
,
Philomène Schiele
,
Stéphane Oudard
,
Gwenaëlle Gravis
,
François Kleinclauss
Journal articles
hal-03612906v1
|
|
Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial
Stéphane Culine
,
Valentin Harter
,
Gwenaelle Gravis
,
Aude Fléchon
,
Christine Chevreau
Journal articles
hal-03625944v1
|
|
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial
François Bertucci
,
Anthony Gonçalves
,
Arnaud Guille
,
José Adelaïde
,
Séverine Garnier
Journal articles
hal-03583277v1
|
|
Advance Approval of Outpatient Chemotherapy via Phone Call Optimizes Healthcare Delivery without Compromising Patient Satisfaction with Care
Patricia Marino
,
Rajae Touzani
,
Lorène Seguin
,
Jean Francois Moulin
,
Myriam Palomares
Journal articles
inserm-03462202v1
|
|
Gastrointestinal Metastases From Primary Renal Cell Cancer: A Single Center Review
Maelle Rony
,
Jean-Philippe Ratone
,
Jochen Walz
,
Geraldine Pignot
,
Fabrice Caillol
Journal articles
hal-03623317v1
|
|
Impact of active surveillance for prostate cancer on the risk of depression and anxiety: Patient-reported outcomes (PROs) from the Vican Prospective Cohort.
Geraldine Pignot
,
Rajae Touzani
,
Patricia Marino
,
Jochen Walz
,
Stanislas Rybikowski
Journal articles
inserm-03665171v1
|
|
Phase 2 study of retifanlimab (INCMGA00012) in patients (pts) with selected solid tumors (POD1UM-203).
Michele Maio
,
Michael Schenker
,
Jacques Medioni
,
Slawomir Mandziuk
,
Margarita Majem
Journal articles
hal-03623326v1
|
|
Endoscopic Ultrasound-Guided Radiofrequency Ablation as an Future Alternative to Pancreatectomy for Pancreatic Metastases from Renal Cell Carcinoma: A Prospective Study
Brice Chanez
,
Fabrice Caillol
,
Jean-Philippe Ratone
,
Christian Pesenti
,
Philippe Rochigneux
Journal articles
hal-03689914v1
|
|
Erratum to ‘Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial’
T.K. Choueiri
,
J. Larkin
,
S. Pal
,
R.J. Motzer
,
B.I. Rini
Journal articles
hal-03623494v1
|
|
Real-world evidence of cabozantinib in patients with metastatic renal cell carcinoma: Results from the CABOREAL Early Access Program
Laurence Albiges
,
Aude Fléchon
,
Christine Chevreau
,
Delphine Topart
,
Gwenaëlle Gravis
Journal articles
hal-03623382v1
|
|
1642P Improve the conditions of lockdown may decrease anxiety among cancer patients during the COVID-19 pandemic
G. Gravis Mescam
,
R. Touzani
,
J. Pakradouni
,
P. Bens Soussan
,
P. Marino
Journal articles
inserm-03667002v1
|
|
665P Role of prior nephrectomy for synchronous metastatic renal cell carcinoma (mRCC) on efficacy in patients treated with avelumab + axitinib (A + Ax) or sunitinib (S): Results from JAVELIN Renal 101
M-O. Grimm
,
M. Oya
,
T.K. Choueiri
,
M. Schmidinger
,
D.I. Quinn
Journal articles
hal-03623392v1
|
|
Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma
Emilien Billon
,
Brice Chanez
,
Philippe Rochigneux
,
Laurence Albiges
,
Cécile Vicier
Journal articles
hal-03623028v1
|
|
Corrigendum: Gastrointestinal Metastases From Primary Renal Cell Cancer: A Single Center Review
Maelle Rony
,
Jean-Philippe Ratone
,
Jochen Walz
,
Geraldine Pignot
,
Fabrice Caillol
Journal articles
hal-03623373v1
|
|
Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: A retrospective study of the GETUG group (Groupe d'Etude des Tumeurs Uro-Genitales)
Mathilde Cancel
,
Gaelle Fromont
,
Cyriac Blonz
,
Christine Chevreau
,
Nathalie Rioux-Leclercq
Journal articles
hal-03476711v1
|
|
L’annonce du cancer au diagnostic de Tumeur de vessie non infiltrant le muscle modifie-t-elle la qualité de vie et l’observance des patients ? Données de la cohorte prospective française VICAN
J Campagna
,
R Touzani
,
G Gravis
,
P Marino
,
J Walz
Journal articles
inserm-03462183v1
|
|
Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial
Bernadett Szabados
,
Alejo Rodriguez-Vida
,
Ignacio Durán
,
Simon Crabb
,
Michiel van Der Heijden
Journal articles
hal-03623603v1
|
|
Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses
Christian Pfister
,
Gwenaelle Gravis
,
Aude Fléchon
,
Michel Soulié
,
Laurent Guy
Journal articles
hal-02995530v1
|
|
Deterioration of Sexual Health in Cancer Survivors Five Years after Diagnosis: Data from the French National Prospective VICAN Survey
Lorène Seguin
,
Rajae Touzani
,
Anne-Déborah Bouhnik
,
Ali Ben Charif
,
Patricia Marino
Journal articles
inserm-03192591v1
|
|
Axitinib in first-line for patients with metastatic papillary renal cell carcinoma: Results of the multicentre, open-label, single-arm, phase II AXIPAP trial
Sylvie Négrier
,
Nathalie Rioux-Leclercq
,
Céline Ferlay
,
Marine Gross-Goupil
,
Gwénaelle Gravis
Journal articles
hal-02552562v1
|
|
Essai GETUG/AFU-V05 VESPER phase III randomisée de chimiothérapie périopératoire (schéma MVAC dose-dense ou GC) dans le cancer de vessie infiltrant localisé. Résultats sur la toxicité de la chimiothérapie et la réponse histologique
C. Pfister
,
G. Gravis
,
A. Flechon
,
M. Soulie
,
Laurent Guy
Journal articles
hal-02995801v1
|
|
Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors
Sotheara Moeung
,
Christine Chevreau
,
Sabrina Marsili
,
Christophe Massart
,
Aude Fléchon
Journal articles
hal-02935842v1
|
|
Estimation of Unbound Carboplatin Clearance From Total Plasma Concentrations as a Means of Facilitating Therapeutic Drug Monitoring
Sotheara Moeung
,
Christine Chevreau
,
Vianney Poinsignon
,
Jérôme Guitton
,
Bénédicte Lelièvre
Journal articles
hal-02481351v1
|
|
Denosumab Toxicity When Combined With Anti-angiogenic Therapies on Patients With Metastatic Renal Cell Carcinoma: A GETUG Study
Aline Guillot
,
Charlotte Joly
,
Philippe Barthélémy
,
Emeline Meriaux
,
Sylvie Négrier
Journal articles
hal-02420071v1
|
|
Neuroendocrine Carcinoma of the Urinary Bladder: A Large, Retrospective Study From the French Genito-Urinary Tumor Group
Marine Sroussi
,
Reza Elaidi
,
Aude Fléchon
,
Marianne Lorcet
,
Delphine Borchiellini
Journal articles
hal-02556645v1
|
|
Adaptation and validation of the memorial anxiety scale for prostate cancer (MAX-PC) in a sample of French men
Rajae Touzani
,
Julien Mancini
,
Jaïs Troian
,
Anne-Déborah Bouhnik
,
Olivier Cussenot
Journal articles
hal-02625852v1
|
|
Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study
Ronan Flippot
,
Cécile Dalban
,
Brigitte Laguerre
,
Delphine Borchiellini
,
Gwénaelle Gravis
Journal articles
hal-02931819v1
|
|
Gender difference in cancer survivors' perceived information 5-years after diagnosis: Data from the French national study - VICAN 5
G. Gravis
,
R. Touzani
,
A-D. Bouhnik
,
P. Marino
,
G. Pignot
Annals of Oncology, 2018, 29 (8)
Journal articles
hal-02143650v1
|
|
Unexpected response to cisplatin rechallenge after immune checkpoint inhibitors in patients with metastatic urothelial carcinoma refractory to platinum regimen
Gwenaelle Gravis
,
Emilien Billon
,
Capucine Baldini
,
Christophe Massard
,
Werner Hilgers
Journal articles
hal-02143638v1
|
|
The role and use of Patient Reported Outcomes in the management of cancer patients
Patricia Marino
,
Marie Bannier
,
Jean-François Moulin
,
Gwenaëlle Gravis
Journal articles
inserm-02096334v1
|
|
Poly (ADP-Ribose) Polymerase Inhibitors for De Novo BRCA2-Null Small-Cell Prostate Cancer
Brice Chanez
,
Max Chaffanet
,
José Adélaide
,
Jeanne Thomassin
,
Séverine Garnier
Journal articles
hal-03623699v1
|
|
Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature review
Philippe Rochigneux
,
Jeanne Thomassin-Piana
,
Sophy Laibe
,
Serge Brunelle
,
Naji Salem
Journal articles
hal-03689938v1
|
|
Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies
Gwenaëlle Gravis
,
Jean-Marie Boher
,
Yu-Hui Chen
,
Glenn Liu
,
Karim Fizazi
Journal articles
inserm-02092595v1
|
|
Assessment of nivolumab exposure and clinical safety of 480 mg every 4 weeks flat-dosing schedule in patients with cancer
G. V. Long
,
S. S. Tykodi
,
J. G. Schneider
,
C. Garbe
,
G. Gravis
Journal articles
hal-02143540v1
|
|
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma
A. Mejean
,
A. Ravaud
,
S. Thezenas
,
S. Colas
,
J. -B. Beauval
Journal articles
hal-02143533v1
|
|
Impact of Patient- and Clinician-Reported Cumulative Toxicity on Quality of Life in Patients With Metastatic Castration-Naive Prostate Cancer
Claudia S. E. W. Schuurhuizen
,
Patricia Marino
,
Annemarie M. J. Braamse
,
Laurien M. Buffart
,
Florence Joly
Journal articles
hal-02143628v1
|
|
Therapeutic Drug Monitoring of Carboplatin in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors: Pharmacokinetic Results of a Phase II Multicenter Study
Sotheara Moeung
,
Christine Chevreau
,
Sophie Broutin
,
Jérome Guitton
,
Bénédicte Lelièvre
Journal articles
hal-01659726v1
|
|
Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naïve Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial
P Lavaud
,
G Gravis
,
S Foulon
,
F Joly
,
S Oudard
Journal articles
hal-01950269v1
|
|
Chemotherapy in hormone-sensitive metastatic prostate cancer: Evidences and uncertainties from the literature
Gwenaëlle Gravis
,
François Audenet
,
Jacques Irani
,
Marc-Olivier Timsit
,
Philippe Barthélémy
Journal articles
hal-01632557v1
|
|
Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?
Damien Pouessel
,
Sylvie Chevret
,
Frédéric Rolland
,
Gwenaëlle Gravis
,
Lionel Geoffrois
Journal articles
hal-01278607v1
|
|
Intermediate analysis of a phase II trial assessing gemcitabine and cisplatin in locoregional or metastatic penile squamous cell carcinoma
Nadine Houédé
,
Laura Dupuy
,
Aude Fléchon
,
Philippe Beuzeboc
,
Gwenaëlle Gravis
Journal articles
hal-01938234v1
|
|
Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity
Christine Pasero
,
Gwenaëlle Gravis
,
Mathilde Guerin
,
Samuel Granjeaud
,
Jeanne Thomassin-Piana
Journal articles
hal-03599184v1
|
|
Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial
Gwenaelle Gravis
,
Jean-Marie Boher
,
Florence Joly
,
Michel Soulié
,
Laurence Albiges
Journal articles
inserm-03343628v1
|
|
Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial
Karim Fizazi
,
Laura Faivre
,
François Lesaunier
,
Remy Delva
,
Gwenaëlle Gravis
Journal articles
hal-01914904v1
|
|
Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favorable MSKCC or ECOG prognostic features
Romain Mathieu
,
Géraldine Pignot
,
Alexandre Ingles
,
Maxime Crépel
,
Pierre Bigot
Journal articles
hal-01260654v1
|
|
Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model
Gwenaelle Gravis
,
Jean-Marie Boher
,
Karim Fizazi
,
Florence Joly
,
Franck Priou
Journal articles
inserm-03353959v1
|
|
Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France
Nadine Houédé
,
Philippe Beuzeboc
,
Sophie Gourgou
,
Diego Tosi
,
Laura Moise
Journal articles
inserm-01264474v1
|
|
Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: Long term outcome of the Temporary Authorization for Use program in France.
Nadine Houede
,
Philippe Beuzeboc
,
Sophie Gourgou
,
Diego Tosi
,
Laura Moise
Journal articles
hal-03578471v1
|
|
A serum metabolomic fingerprint of bevacizumab and temsirolimus combination as first-line treatment of metastatic renal cell carcinoma
Elodie Jobard
,
Ellen Blanc
,
Sylvie Négrier
,
Bernard Escudier
,
Gwenaëlle Gravis
Journal articles
hal-01234309v1
|
|
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project
A. Kramar
,
S. Negrier
,
R. Sylvester
,
S. Joniau
,
P. Mulders
Journal articles
hal-01913181v1
|
|
Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial
K. Fizazi
,
G. Gravis
,
Aude Flechon
,
L. Geoffrois
,
C. Chevreau
Journal articles
hal-02168058v1
|
|
Patients’ self-assessment versus investigators’ evaluation in a phase III trial in non-castrate metastatic prostate cancer (GETUG-AFU 15).
Gwenaëlle Gravis
,
Patricia Marino
,
Florence Joly
,
Stéphane Oudard
,
Franck Priou
Journal articles
hal-01917876v1
|
|
VEGFR1 single nucleotide polymorphisms associated with outcome in patients with metastatic renal cell carcinoma treated with sunitinib - a multicentric retrospective analysis
Benoit Beuselinck
,
Alexandra Karadimou
,
Diether Lambrechts
,
Bart Claes
,
Pascal Wolter
Journal articles
hal-01064635v1
|
|
FGFR1 and WT1 are markers of human prostate cancer progression.
Elizabeth Devilard
,
Franck Bladou
,
Olivier Ramuz
,
Gilles Karsenty
,
Jean-Philippe Dalès
Journal articles
inserm-00121110v1
|
|
Quality of life of breast cancer patients receiving high-dose-intensity chemotherapy: impact of length of cycles
Dominique Genre
,
C. Protière
,
Geneviève Macquart-Moulin
,
G. Gravis
,
Jacques Camerlo
Journal articles
inserm-03199677v1
|
|
Modulations of dose intensity of doxorubicin and cyclophosphamide in association with G-CSF and peripheral blood stem cells in adjuvant chemotherapy for breast cancer: comparative evaluation of completion and safety of three intensive regimens
D. Genre
,
P. Viens
,
F. Bertucci
,
C Chabannon
,
G. Gravis
Journal articles
inserm-03199676v1
|